张志将

教授、博士生导师

zhang22968@163.com


系别:流行病与卫生统计学系

联系电话:027-68759118


个人简介

匹兹堡大学生物统计学硕士、流行病学博士,哈佛大学分子流行病学硕士,复旦大学流行病学硕士,南京医科大学预防医学学士。主要从事流行病学现场调研、分子流行病学机制研究、卫生统计与数据分析。发表科研论文100余篇,其中“ESI热点论文”1篇,“ESI高被引论文”6篇。参编国家级教材4本。


主要研究领域

  1. 糖尿病防控;代谢紊乱与肿瘤;

  2. 心血管疾病的病因机制、生物标志物;冠心病介入治疗效果评价;

  3. 新再发传染病学;

  4. 生存分析、大数据分析、Meta分析


代表性论文

  1. Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ*. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA. 2020 Feb 14;323(13):1313-4. (影响因子 45.54)

  2. Zhang ZJ*, Yu XJ#, Fu T#, Liu Y, Jiang Y, Yang BX, Bi Y. Novel coronavirus infection in newborn babies aged <28 days in China. Eur Respir J. 2020 Jun 18;55(6):2000697.      (影响因子 12.339)

  3. Liu YL#, Ren J#, Yuan JP#, Zhang ZJ#, Guo WY, Guan Y, Moeckel G, Ahuja N, Fu T*. Postoperative onset and detection of SARS-CoV-2 in surgically resected specimens from gastrointestinal cancer patients with pre/asymptomatic COVID-19. Annals of Surgery 2020; 272(6):e321-e328. (影响因子 10.13)

  4. Wang Y, Liu X, Yan P, Tang J, Chen T, Sun Y, Zhou W, Bi Y, Zhang ZJ*. Effect of metformin on the risk of prostate cancer in patients with type 2 diabetes by considering different confounding factors: a meta-analysis of observational studies. Eur J Cancer Prev. 2020      Jan;29(1):42-52. (影响因子 2.330)

  5. Chen T, Wei M, Liu Y, Wang H, Zhou W, Bi Y, Zhang ZJ*. Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China. J Gen Intern Med. 2020 Feb;35(2):593. (影响因子 4.606)

  6. Wang Y, Fu T, Liu Y, Yang G, Yu C, Zhang ZJ*.The Association between Metformin and Survival of Head and Neck Cancer: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies. Curr Pharm Des. 2020;26(26):3161-3170.

  7. Wang Y, Liu X, Yan P, Bi Y, Liu Y, Zhang ZJ*. Association Between Type 1 and Type 2 Diabetes and Risk of non-Hodgkin's Lymphoma: A Meta-Analysis of Cohort Studies. Diabetes Metab 2020 ;46(1):8-19. (影响因子 4.008)

  8. Liu Y, Li RL, Song Y, Zhang ZJ*. The Role of  Environmental Tax in Alleviating the Impact of Environmental Pollution on Residents' Happiness in China. Int J Environ Res Public Health. 2019 Nov 19;16(22):4574. (影响因子 2.468)

  9. Wang Y, Liu X, Yan P, Bi Y, Liu Y, Zhang ZJ*. No Effect of Metformin on Ovarian Cancer Survival: A Systematic Review and Meta-Analysis of Cohort Studies. Curr Pharm Des. 2019;25(23):2595-2601. (影响因子 2.412)

  10. Liu X, Jiang J, Yu C, Wang Y, Sun Y, Tang J, Chen T, Bi Y, Liu Y, Zhang ZJ*. Secular trends in incidence and mortality of bladder cancer in China, 1990-2017: A joinpoint and age-period-cohort analysis. Cancer Epidemiol. 2019 Aug;61:95-103. (影响因子 2.619)

  11.  Zhang ZJ*. Metformin and Reduced Risk of Cancer in the Hong Kong Diabetes Registry: Real Effect or Immortal Time Bias? J Gen Intern Med. 2019 Jul;34(7):1154-1157. (影响因子 4.606)

  12. Wei M, Liu Y, Bi Y, Zhang ZJ*. Metformin and pancreatic cancer survival: Real effect or immortal time bias? Int J Cancer. 2019 Oct 1;145(7):1822-1828. (影响因子 4.982)

  13.  Liu X, Yu C, Bi Y, Zhang ZJ*. Trends and Age-Period-Cohort Effect on Incidence and Mortality of Prostate Cancer From 1990 to 2017 in China. Public Health. 2019 Jul;172:70-802. (影响因子 1.696)

  14.  Liu X, Bi Y, Wang H, Meng R, Zhou W, Zhang G, Yu C, Zhang ZJ*. Different trends in colorectal cancer mortality between age groups in China: an age-period-cohort and joinpoint analysis. Public Health. 2019 Jan;166:45-52. (影响因子 1.696)

  15. Zhang ZJ*, Yuan J, Bi Y, Wang C, Liu Y. The effect of metformin on biomarkers and survivals for breast cancer- a systematic review and meta-analysis of randomized clinical trials. Pharmacol Res. 2019 Mar;141:551-555. (影响因子 5.574)

  16.  Liu Y, Bi Y, Chen Y, Shi L, Zhang ZJ*. The Association Between Stent Postdilation and Death in Patients With Acute Coronary Syndrome. Can J Cardiol. 2019 Feb;35(2):230.e5. (影响因子 5.592)

  17.  Liu X, Yu C, Wang Y, Bi Y, Liu Y, Zhang ZJ*. Trends in the Incidence and Mortality of Diabetes in China from 1990 to 2017: A Joinpoint and Age-Period-Cohort Analysis. Int J Environ Res Public Health. 2019 Jan 8;16(1). pii: E158. (影响因子 2.468)

  18. Wang Y, Sun Y, Tang J, Zhou W, Liu X, Bi Y, Zhang ZJ*. Does diabetes decrease the risk of glioma? A systematic review and meta-analysis of observational studies. Ann Epidemiol. 2019 Feb;30:22-29.e3. (影响因子 2.55)

  19. Wei M, Zhou W, Bi Y, Wang H, Liu Y, Zhang ZJ*. Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China. J Gen Intern Med. 2019 Feb;34(2):281-284. (影响因子 4.606)

  20.  Wang L, Yu C, Liu Y, Wang J, Li C, Wang Q, Wang P, Wu S, Zhang ZJ*. Lung Cancer Mortality Trends in China from 1988 to 2013: New Challenges and Opportunities for the Government. Int J Environ Res Public Health 2016;13(11). pii: E1052. (影响因子 2.468)

  21.  Zhang ZJ*, Bi Y, Li S, Zhang Q, Zhao G, Guo Y, Song Q. Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis. Am J Epidemiol 2014;180(1):11-4. (影响因子 4.473)

  22. Zhang ZJ*, Li S. The prognostic value of metformin for cancer patients with concurrent diabetes- a systematic review and meta-analysis. Diabetes Obes Metab 2014; 16(8):707-10. (影响因子 6.133)

  23.  Zhang ZJ*, Zhao G, Song Y. Attention is needed for women in the control of diabetic complications in China. Acta Diabetol 2014;51(6):1081-2. (影响因子 2.996)

  24.  Zhang ZJ.* Systematic review on the association between F2-isoprostanes and cardiovascular disease. Annals of Clinical Biochemistry 2013;50(Pt 2):108-14. (影响因子 1.893)

  25. Zhang ZJ,* Zheng ZJ, Shi R, Su Q, Jiang Q, Kip KE. Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab 2012;97(7):2347-53. (影响因子:5.399;被引用127次)

  26.  Zhang ZJ*, Zheng ZJ, Kan H, Song Y, Cui W, Zhao G, Kip KE. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes-a meta-analysis. Diabetes Care 2011; 34(10):2323-8. (影响因子:16.019;被引用182次)

  27.  Zhang ZJ*, Hao K, Shi R, Zhao G, Jiang GX, Song Y, Xu X, Ma J. Glutathione S-Transferase M1 (GSTM1) and Glutathione S-Transferase T1 (GSTT1) Null Polymorphisms, Smoking, and Their Interaction in Oral Cancer: A HuGE Review and Meta-Analysis. American Journal of Epidemiology 2011; 173(8):847-57.(影响因子:5.216)

  28.  Zhang ZJ*. Mortality benefit and reduced need for repeat revascularization with statin therapy among patients undergoing percutaneous coronary intervention. Journal of Cardiology 2011; 57(3):360.

  29.  Zhang ZJ*, Marroquin OC, Stone RA, Weissfeld JL, Mulukutla SR, Selzer F, Kip KE. Differential effects of post-dilation following stent deployment in patients presenting with and without acute myocardial infarction. American Heart Journal 2010, 160(5):979-86. (影响因子:4.153)

  30. Zhang ZJ*, Cheng Q, Jiang GX, Marroquin OC. Statins in prevention of repeat revascularization after percutaneous coronary intervention-A meta-analysis of randomized clinical trial. Pharmacological Research 2010; 61(4):316-20. (影响因子:5.893)

  31.  Zhang ZJ*, Marroquin OC, Weissfeld JL, Stone RA, Mulukutla SR, Williams DO, Selzer F, Kip KE. Beneficial effects of statins after percutaneous coronary intervention. European Journal of Cardiovascular Prevention and Rehabilitation 2009; 16(4): 445-50. (影响因子:2.03)

  32. 周昇, 张志将*, 袁占鹏, 万琴, 张雪峰. 安陆市居民戊肝的知识、态度和行为现状调查. 中国循证医学杂志 , 2020, 8:923-929.

  33. 周薇, 毕勇毅,王丽君,刘晓雪,张志将*, 宇传华. 中国女性1987-2014年乳腺癌死亡趋势的Joinpoint 回归分析. 中南大学学报(医学版),2018,43(2): 210-215.

  34. 周薇, 段志洲, 张杰, 牛治平, 魏敏, 毕勇毅, 宇传华, 张志将*.妊娠期糖尿病对新生儿出生体重的影响. 公共卫生与预防医学, 2017, 28(6):52-55.

  35. 周薇, 张志将*, 王丽君, 刘晓雪, 宇传华. 中国子宫颈癌1987-2014年死亡趋势的Joinpoint回归分析. 中国癌症杂志, 2017, 27(8):634-640. (杂志社颁发“2017年优秀论文”荣誉证书)

  36. 赵志伟, 张志将*,柯岩,袁劲松,贾岩龙,杨涛,杨亚刚.苍白球MR信号改变在新生儿急性高胆红素脑病中的诊断价值分析. 现代诊断与治疗,2017,28(17):3221-3222

  37. 王丽君, 宇传华, 张志将, 燕虹. 中国居民1987—2014年肺癌死亡趋势分析. 中国公共卫生杂志, 2017, 33(1): 42-46.

  38. 张志将*, 雷正龙,谢铮,尹慧,郭岩. 全球消灭脊髓灰质炎行动25周年的回顾与展望:消灭最后的千分之一. 中国全科医学, 2014, 17(27):3167-70. (伴发编者按)

  39. 张志将, 李十月,燕虹,邹宇量,郭毅,向浩,陈华,毛宗福. 建构主义在流行病学教学上的应用. 中国高等医学教育, 2014, 2:16-7. (中华医学会医学教育分会和中国高等教育学会医学教育专业委员会联合颁发“2014年度医学教育和医学教育管理百篇优秀论文评选”二等奖)

  40. 张志将, 林松柏, 赵根明, 韩明. 上海市1971~2000年糖尿病引起的疾病负担趋势分析. 中华预防医学杂志 2004; 38(5): 338.

  41. 张志将, 赵根明, 吴元民, 江萍; 人体测量指标和糖尿病危险状态指标的相关关系; 中国公共卫生 2002;689-690.

  42. 张志将, 吴元民, 江萍,赵根明. 社区自然人群中糖尿病慢性并发症危险因素的探索研究. 中国全科医学 2001; 4(12):970-972.

*通讯作者



主编与参编著作

张志将副主编,见:王重建主编. Epidemiology. 郑州:郑州大学出版社

张志将编委, 见沈洪兵主编. Epidemiology. 北京:人民卫生出版社

张志将编委, 见郝元涛, 陈心广主编. 全球健康研究方法. 北京:人民卫生出版社


社会服务

Journal of General Internal Medicine (中科院二区)编委

中国循证医学杂志 编委

湖北省预防医学会流行病学分会第七届委员会委员

湖北省预防医学会心血管疾病预防与控制专业第一届委员会委员


Baidu
sogou